Interactions between an HMG-1 protein and members of the Rel family.
about
HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoterOver- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarismA homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interactionUpregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotypeThe implication and potential applications of high-mobility group box 1 protein in breast cancerPolyphenol Compound as a Transcription Factor InhibitorRAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophagesThe high mobility group box chromosomal protein 1 is expressed in the human and rat testis where it may function as an antibacterial factorMutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humansHigh mobility group protein-B1 interacts with sterol regulatory element-binding proteins to enhance their DNA binding.High-mobility group box 1 and cancer.Genetic modifier screens on Hairless gain-of-function phenotypes reveal genes involved in cell differentiation, cell growth and apoptosis in Drosophila melanogaster.HMGB1 in health and disease.Cross signaling, cell specificity, and physiology.Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomasDown-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathwayRituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma.HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis.Life after death: targeting high mobility group box 1 in emergent cancer therapies.Transcription factors: their potential as targets for an individualized therapeutic approach to cancer.High-mobility group box 1, oxidative stress, and disease.The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins.Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1.NF-kappaB: Two Sides of the Same Coin.Recruitment of Drosophila Polycomb group proteins to chromatin by DSP1.Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma.Dual roles for HMGB1: DNA binding and cytokineAssociation ofHMGB1andHMGB2genetic polymorphisms with lung cancer chemotherapy response
P2860
Q24292041-D61FF707-1D61-444F-84E7-78F6C5CEECB9Q24531513-FC9A4588-7308-4C40-ABD5-9771EC3DC93DQ24681401-22D3A70D-6BEF-4A98-9947-A094CD994F8DQ24685044-5EABB664-BC3E-4C58-B3A5-69C14A55E286Q26744069-9B88D5A0-76DF-4816-A220-494C39FD620AQ26777064-AB8429A4-D5BF-4E41-A22D-C56CAB2C7053Q28568915-17BA7DDC-CC66-4672-8593-B136B47ACAEBQ28582285-DC31A023-AA5F-47F3-A3A3-3E026E779E37Q28586560-65E243F5-6447-4FC8-8E93-0025B2A282FAQ33220241-EC58EC6D-073B-4C2F-83CC-98E3945ECEADQ33638306-56A587D6-604D-450A-A4E6-C0B4D5952273Q34589848-8F868676-4A31-4225-BC56-F0FCE0AFD1CFQ34622835-EC6E6E56-7A64-4E00-A2D8-4F5AC4E32491Q34675896-1E5255E0-F343-43F2-8903-688F54B72D0EQ35761034-018B5673-6ED1-4E5D-8DCF-8728AA823099Q35913266-0FAF5EFD-11F3-4BD5-A482-AE5101B6C8DAQ36413919-05D5C925-3B8C-456E-818D-823BE352EA96Q36511773-B3A396D0-C696-4FDB-9D4F-FF07F8A4F09DQ36562901-19265375-5B32-40D7-94BC-2189EF222A7EQ37290948-9C21361E-564C-467F-A8B1-62E755676EAEQ37802381-F41AC780-9A2E-4CD8-B9A2-281D1A0F3435Q38289346-8BA934D6-4362-48B4-87C8-15B8EBEC667BQ38755966-12653F70-6751-4E73-A4B3-9ADF1455E15EQ39675422-03A05929-F219-4423-A43A-1C856BF0099EQ43750943-918A1BF9-177B-4DE3-9AC9-E726B452DE94Q47556651-3690ADDD-8F89-4885-8989-083EE50918BCQ52054093-9207AAE3-9924-466A-8410-6F6DF72906F9Q52562715-AD39C1AA-487F-45E1-AB8A-F3DFC62F43C6Q56904863-CEB2C920-0BED-4D3A-AEF1-D8985A2C4E26Q57500224-9714E377-28FC-4585-8D93-2814A6A0967C
P2860
Interactions between an HMG-1 protein and members of the Rel family.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Interactions between an HMG-1 protein and members of the Rel family.
@ast
Interactions between an HMG-1 protein and members of the Rel family.
@en
type
label
Interactions between an HMG-1 protein and members of the Rel family.
@ast
Interactions between an HMG-1 protein and members of the Rel family.
@en
prefLabel
Interactions between an HMG-1 protein and members of the Rel family.
@ast
Interactions between an HMG-1 protein and members of the Rel family.
@en
P2093
P2860
P356
P1476
Interactions between an HMG-1 protein and members of the Rel family.
@en
P2093
P2860
P304
10679-10683
P356
10.1073/PNAS.96.19.10679
P407
P577
1999-09-01T00:00:00Z